Fibroblast growth factor 8b causes progressive stromal and epithelial changes in the: Epididymis and degeneration of the seminiferous epithelium in the testis of transgenic mice1

Biology of Reproduction

Volumn 86, Issue 5, 2012, Pages

  Elo, Teresa ^a   Sipilä, Petra ^a   Valve, Eeva ^a   Kujala, Paula ^b   Toppari, Jorma ^a   Poutanen, Matti ^a   Härkönen, Pirkko ^a,c  

^a UNIVERSITY OF TURKU   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Epididymis; Fibroblast growth factor 8; Growth factors; Male reproductive tract; Stroma; Testis; Transgenic mouse; Transgenic knockout model

Indexed keywords

ANDROGEN RECEPTOR; APOLIPOPROTEIN D; CONNECTIVE TISSUE GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 8B; FIBROBLAST GROWTH FACTOR RECEPTOR 1; LAMININ; OSTEOPONTIN; SMOOTH MUSCLE ACTIN; UNCLASSIFIED DRUG; ACTIN; CTGF PROTEIN, MOUSE; FGF8 PROTEIN, HUMAN; FGFR1 PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR 8; SPP1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; CONTROLLED STUDY; EPIDIDYMIS; EPITHELIUM CELL; IMMUNOHISTOCHEMISTRY; MALE; MALE INFERTILITY; MOUSE; NONHUMAN; OLIGOSPERMIA; PRIORITY JOURNAL; PROSTATE; PROTEIN EXPRESSION; SEMINIFEROUS TUBULE EPITHELIUM; SIGNAL TRANSDUCTION; STAINING; STROMA; STROMA CELL; TESTIS; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL LINE; GENETICS; HUMAN; HYPERTROPHY; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

ACTINS; ANIMALS; APOLIPOPROTEINS D; CELL LINE; CONNECTIVE TISSUE GROWTH FACTOR; EPIDIDYMIS; FIBROBLAST GROWTH FACTOR 8; HUMANS; HYPERTROPHY; INFERTILITY, MALE; LAMININ; MALE; MICE; MICE, TRANSGENIC; OSTEOPONTIN; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, ANDROGEN; SEMINIFEROUS EPITHELIUM; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84864004520     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.111.097352     Document Type: Article

References (53)

1. Beenken A, Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov 2009; 8:235-253.
2. Cotton LM, O'Bryan MK, Hinton BT. Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction. Endocr Rev 2008; 29:193-216.
3. Fon Tacer K, Bookout AL, Ding X, Kurosu H, John GB, Wang L, Goetz R, Mohammadi M, Kuro-o M, Mangelsdorf DJ, Kliewer SA. Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol Endocrinol 2010; 24:2050-2064.
4. Tomsig JL, Turner TT. Growth factors and the epididymis. J Androl 2006; 27:348-357.
5. Johnston DS, Jelinsky SA, Bang HJ, DiCandeloro P, Wilson E, Kopf GS, Turner TT. The mouse epididymal transcriptome: transcriptional profiling of segmental gene expression in the epididymis. Biol Reprod 2005; 73: 404-413.
6. Kirby JL, Yang L, Labus JC, Hinton BT. Characterization of fibroblast growth factor receptors expressed in principal cells in the initial segment of the rat epididymis. Biol Reprod 2003; 68:2314-2321.
7. Lan ZJ, Labus JC, Hinton BT. Regulation of gamma-glutamyl transpeptidase catalytic activity and protein level in the initial segment of the rat epididymis by testicular factors: role of basic fibroblast growth factor. Biol Reprod 1998; 58:197-206.
8. Mayerhofer A, Russell LD, Grothe C, Rudolf M, Gratzl M. Presence and localization of a 30-kDa basic fibroblast growth factor-like protein in rodent testes. Endocrinology 1991; 129:921-924.
9. Koike S, Noumura T. Cell- and stage-specific expression of basic FGF in the developing rat gonads. Growth Regul 1994; 4:77-81.
10. Cancilla B, Risbridger GP. Differential localization of fibroblast growth factor receptor-1, -2, -3, and -4 in fetal, immature, and adult rat testes. Biol Reprod 1998; 58:1138-1145.
11. Cancilla B, Davies A, Ford-Perriss M, Risbridger GP. Discrete cell- and stage-specific localization of fibroblast growth factors and receptor expression during testis development. J Endocrinol 2000; 164:149-159.
12. Cotton L, Gibbs GM, Sanchez-Partida LG, Morrison JR, de Kretser DM, O'Bryan MK. FGFR-1 signaling is involved in spermiogenesis and sperm capacitation. J Cell Sci 2006; 119:75-84.
13. Chua SS, Ma ZQ, Gong L, Lin SH, DeMayo FJ, Tsai SY. Ectopic expression of FGF-3 results in abnormal prostate and Wolffian duct development. Oncogene 2002; 21:1899-1908.
14. Xu B, Yang L, Lye RJ, Hinton BT. p-MAPK1/3 and DUSP6 regulate epididymal cell proliferation and survival in a region-specific manner in mice. Biol Reprod 2010; 83:807-817.
15. Tanaka A, Miyamoto K, Minamino N, Takeda M, Sato B, Matsuo H, Matsumoto K. Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. Proc Natl Acad Sci U S A 1992; 89: 8928-8932.
16. MacArthur CA, Lawshe A, Shankar DB, Heikinheimo M, Shackleford GM. FGF-8 isoforms differ in NIH3T3 cell transforming potential. Cell Growth Differ 1995; 6:817-825.
17. Zhang X, Ibrahimi OA, Olsen SK, Umemori H, Mohammadi M, Ornitz DM. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem 2006; 281:15694-15700.
18. Ghosh AK, Shankar DB, Shackleford GM, Wu K, T'Ang A, Miller GJ, Zheng J, Roy-Burman P. Molecular cloning and characterization of human FGF8 alternative messenger RNA forms. Cell Growth Differ 1996; 7: 1425-1434.
19. MacArthur CA, Lawshe A, Xu J, Santos-Ocampo S, Heikinheimo M, Chellaiah AT, Ornitz DM. FGF-8 isoforms activate receptor splice forms that are expressed in mesenchymal regions of mouse development. Development 1995; 121:3603-3613.
20. Leung HY, Dickson C, Robson CN, Neal DE. Over-expression of fibroblast growth factor-8 in human prostate cancer. Oncogene 1996; 12: 1833-1835.
21. Valve EM, Nevalainen MT, Nurmi MJ, Laato MK, Martikainen PM, Harkonen PL. Increased expression of FGF-8 isoforms and FGF receptors in human premalignant prostatic intraepithelial neoplasia lesions and prostate cancer. Lab Invest 2001; 81:815-826.
22. Gnanapragasam VJ, Robinson MC, Marsh C, Robson CN, Hamdy FC, Leung HY. FGF8 isoform b expression in human prostate cancer. Br J Cancer 2003; 88:1432-1438.
23. Suzuki K, Tokue A, Kamiakito T, Kuriki K, Saito K, Tanaka A. Predominant expression of fibroblast growth factor (FGF) 8, FGF4, and FGF receptor 1 in nonseminomatous and highly proliferative components of testicular germ cell tumors. Virchows Arch 2001; 439:616-621.
24. Ruohola JK, Viitanen TP, Valve EM, Seppanen JA, Loponen NT, Keskitalo JJ, Lakkakorpi PT, Harkonen PL. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells. Cancer Res 2001; 61:4229-4237.
25. Mattila MM, Ruohola JK, Valve EM, Tasanen MJ, Seppanen JA, Harkonen PL. FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells. Oncogene 2001; 20: 2791-2804.
26. Valta MP, Tuomela J, Vuorikoski H, Loponen N, Vaananen RM, Pettersson K, Vaananen HK, Harkonen PL. FGF-8b induces growth and rich vascularization in an orthotopic PC-3 model of prostate cancer. J Cell Biochem 2009; 107:769-784.
27. Valta MP, Tuomela J, Bjartell A, Valve E, Vaananen HK, Harkonen P. FGF-8 is involved in bone metastasis of prostate cancer. Int J Cancer 2008; 123:22-31.
28. Song Z, Wu X, Powell WC, Cardiff RD, Cohen MB, Tin RT, Matusik RJ, Miller GJ, Roy-Burman P. Fibroblast growth factor 8 isoform B overexpression in prostate epithelium: a new mouse model for prostatic intraepithelial neoplasia. Cancer Res 2002; 62:5096-5105.
29. Elo TD, Valve EM, Seppanen JA, Vuorikoski HJ, Makela SI, Poutanen M, Kujala PM, Harkonen PL. Stromal activation associated with development of prostate cancer in prostate-targeted fibroblast growth factor 8b transgenic mice. Neoplasia 2010; 12:915-927.
30. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(_Delta Delta C(T)) Method. Methods 2001; 25:402-408.
31. Huhtaniemi I, Nikula H, Rannikko S. Treatment of prostatic cancer with a gonadotropin-releasing hormone agonist analog: acute and long term effects on endocrine functions of testis tissue. J Clin Endocrinol Metab 1985; 61:698-704.
32. Zhou Q, Clarke L, Nie R, Carnes K, Lai LW, Lien YH, Verkman A, Lubahn D, Fisher JS, Katzenellenbogen BS, Hess RA. Estrogen action and male fertility: roles of the sodium/hydrogen exchanger-3 and fluid reabsorption in reproductive tract function. Proc Natl Acad Sci U S A 2001; 98:14132-14137.
33. Davies B, Baumann C, Kirchhoff C, Ivell R, Nubbemeyer R, Habenicht UF, Theuring F, Gottwald U. Targeted deletion of the epididymal receptor HE6 results in fluid dysregulation and male infertility. Mol Cell Biol 2004; 24:8642-8648.
34. Seethammagari MR, Xie X, Greenberg NM, Spencer DM. EZC-prostate models offer high sensitivity and specificity for noninvasive imaging of prostate cancer progression and androgen receptor action. Cancer Res 2006; 66:6199-6209.
35. Zhang J, Thomas TZ, Kasper S, Matusik RJ. A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo. Endocrinology 2000; 141:4698-4710.
36. Wu X, Wu J, Huang J, Powell WC, Zhang J, Matusik RJ, Sangiorgi FO, Maxson RE, Sucov HM, Roy-Burman P. Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mech Dev 2001; 101:61-69.
37. Jin C, McKeehan K, Wang F. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens. Prostate 2003; 57:160-164.
38. Kasper S, Smith JA Jr. Genetically modified mice and their use in developing therapeutic strategies for prostate cancer. J Urol 2004; 172: 12-19.
39. Sharrocks AD. The ETS-domain transcription factor family. Nat Rev Mol Cell Biol 2001; 2:827-837.
40. Roehl H, Nusslein-Volhard C. Zebrafish pea3 and erm are general targets of FGF8 signaling. Curr Biol 2001; 11:503-507.
41. Fox SA, Yang L, Hinton BT. Identifying putative contraceptive targets by dissecting signal transduction networks in the epididymis using an in vivo electroporation (electrotransfer) approach. Mol Cell Endocrinol 2006; 250: 196-200.
42. Mott NN, Chung WC, Tsai PS, Pak TR. Differential fibroblast growth factor 8 (FGF8)-mediated autoregulation of its cognate receptors, Fgfr1 and Fgfr3, in neuronal cell lines. PLoS One 2010; 5:e10143.
43. Ruohola JK, Valve EM, Vainikka S, Alitalo K, Harkonen PL. Androgen and fibroblast growth factor (FGF) regulation of FGF receptors in S115 mouse mammary tumor cells. Endocrinology 1995; 136:2179-2188.
44. Kwabi-Addo B, Ozen M, Ittmann M. The role of fibroblast growth factors and their receptors in prostate cancer. Endocr Relat Cancer 2004; 11: 709-724.
45. Andre F, Job B, Dessen P, Tordai A, Michiels S, Liedtke C, Richon C, Yan K, Wang B, Vassal G, Delaloge S, Hortobagyi GN, et al. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Clin Cancer Res 2009; 15: 441-451.
46. Tomlinson DC, Lamont FR, Shnyder SD, Knowles MA. Fibroblast growth factor receptor 1 promotes proliferation and survival via activation of the mitogen-activated protein kinase pathway in bladder cancer. Cancer Res 2009; 69:4613-4620.
47. Arnaud-Dabernat S, Yadav D, Sarvetnick N. FGFR3 contributes to intestinal crypt cell growth arrest. J Cell Physiol 2008; 216:261-268.
48. Arnaud-Dabernat S, Kritzik M, Kayali AG, Zhang YQ, Liu G, Ungles C, Sarvetnick N. FGFR3 is a negative regulator of the expansion of pancreatic epithelial cells. Diabetes 2007; 56:96-106.
49. Jang JH. Reciprocal relationship in gene expression between FGFR1 and FGFR3: implication for tumorigenesis. Oncogene 2005; 24:945-948.
50. Mendive F, Laurent P, Van Schoore G, Skarnes W, Pochet R, Vassart G. Defective postnatal development of the male reproductive tract in LGR4 knockout mice. Dev Biol 2006; 290:421-434.
51. Basciani S, Mariani S, Arizzi M, Brama M, Ricci A, Betsholtz C, Bondjers C, Ricci G, Catizone A, Galdieri M, Spera G, Gnessi L. Expression of platelet-derived growth factor (PDGF) in the epididymis and analysis of the epididymal development in PDGF-A, PDGF-B, and PDGF receptor beta deficient mice. Biol Reprod 2004; 70:168-177.
52. Ganem JP, Jhaveri FM, Marroum MC. Primary adenocarcinoma of the epididymis: case report and review of the literature. Urology 1998; 52: 904-908.
53. Sipila P, Cooper TG, Yeung CH, Mustonen M, Penttinen J, Drevet J, Huhtaniemi I, Poutanen M. Epididymal dysfunction initiated by the expression of simian virus 40 T-antigen leads to angulated sperm flagella and infertility in transgenic mice. Mol Endocrinol 2002; 16:2603-2617.